Francesco Trepiccione1, Federica Prosperi1,2, Luigi Regenburgh de la Motte1,2, Christian A Hübner3, Regine Chambrey4, Dominique Eladari5, Giovambattista Capasso1,2. 1. Department of Cardiothoracic and Respiratory Science, University of Campania "Luigi Vanvitelli," Naples, Italy. 2. Biogem S.c.a.r.l., Research Institute Gaetano Salvatore, Ariano Irpino, Italy. 3. Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, Germany. 4. Inserm U1188, Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI), Université de La Réunion, France. 5. Service d'Explorations Fonctionnelles Rénales, Hôpital Felix Guyon, CHU de la Réunion, Saint-Denis, Ile de la Réunion, France.
Abstract
BACKGROUND: Distal renal tubular acidosis (dRTA) is characterized by an impairment of the urinary acidification process in the distal nephron. Complete or incomplete metabolic acidosis coupled with inappropriately alkaline urine are the hallmarks of this condition. Genetic forms of dRTA are caused by loss of function mutations of either SLC4A1, encoding the AE1 anion exchanger, or ATP6V1B1 and ATP6V0A4, encoding for the B1 and a4 subunits of the vH+ATPase, respectively. These genes are crucial for the function of A-type intercalated cells (A-IC) of the distal nephron. SUMMARY: Alterations of acid-base homeostasis are variably associated with hypokalemia, hypercalciuria, nephrocalcinosis or nephrolithiasis, and a salt-losing phenotype. Here we report the diagnostic test and the underlying physiopathological mechanisms. The molecular mechanisms identified so far can explain the defect in acid secretion, but do not explain all clinical features. We review the latest experimental findings on the pathogenesis of dRTA, reporting mechanisms that are instrumental for the clinician and potentially inspiring a novel therapeutic strategy. KEY MESSAGE: Primary dRTA is usually intended as a single-cell disease because the A-IC are mainly affected. However, novel evidence shows that different cell types of the nephron may contribute to the signs and symptoms, moving the focus from a single-cell towards a renal disease.
BACKGROUND: Distal renal tubular acidosis (dRTA) is characterized by an impairment of the urinary acidification process in the distal nephron. Complete or incomplete metabolic acidosis coupled with inappropriately alkaline urine are the hallmarks of this condition. Genetic forms of dRTA are caused by loss of function mutations of either SLC4A1, encoding the AE1 anion exchanger, or ATP6V1B1 and ATP6V0A4, encoding for the B1 and a4 subunits of the vH+ATPase, respectively. These genes are crucial for the function of A-type intercalated cells (A-IC) of the distal nephron. SUMMARY: Alterations of acid-base homeostasis are variably associated with hypokalemia, hypercalciuria, nephrocalcinosis or nephrolithiasis, and a salt-losing phenotype. Here we report the diagnostic test and the underlying physiopathological mechanisms. The molecular mechanisms identified so far can explain the defect in acid secretion, but do not explain all clinical features. We review the latest experimental findings on the pathogenesis of dRTA, reporting mechanisms that are instrumental for the clinician and potentially inspiring a novel therapeutic strategy. KEY MESSAGE: Primary dRTA is usually intended as a single-cell disease because the A-IC are mainly affected. However, novel evidence shows that different cell types of the nephron may contribute to the signs and symptoms, moving the focus from a single-cell towards a renal disease.
Authors: Stephen Walsh; Clare M Turner; Ashley Toye; Carsten Wagner; Philippe Jaeger; Christopher Laing; Robert Unwin Journal: Nephrol Dial Transplant Date: 2007-01-05 Impact factor: 5.992
Authors: P Jarolim; C Shayakul; D Prabakaran; L Jiang; A Stuart-Tilley; H L Rubin; S Simova; J Zavadil; J T Herrin; J Brouillette; M J Somers; E Seemanova; C Brugnara; L M Guay-Woodford; S L Alper Journal: J Biol Chem Date: 1998-03-13 Impact factor: 5.157
Authors: E H Stover; K J Borthwick; C Bavalia; N Eady; D M Fritz; N Rungroj; A B S Giersch; C C Morton; P R Axon; I Akil; E A Al-Sabban; D M Baguley; S Bianca; A Bakkaloglu; Z Bircan; D Chauveau; M-J Clermont; A Guala; S A Hulton; H Kroes; G Li Volti; S Mir; H Mocan; A Nayir; S Ozen; J Rodriguez Soriano; S A Sanjad; V Tasic; C M Taylor; R Topaloglu; A N Smith; F E Karet Journal: J Med Genet Date: 2002-11 Impact factor: 6.318
Authors: Pauline I A de Bruijn; Casper K Larsen; Sebastian Frische; Nina Himmerkus; Helle A Praetorius; Markus Bleich; Jens Leipziger Journal: Am J Physiol Renal Physiol Date: 2015-07-15
Authors: Paul A Stehberger; Boris E Shmukler; Alan K Stuart-Tilley; Luanne L Peters; Seth L Alper; Carsten A Wagner Journal: J Am Soc Nephrol Date: 2007-04-04 Impact factor: 10.121
Authors: A N Smith; J Skaug; K A Choate; A Nayir; A Bakkaloglu; S Ozen; S A Hulton; S A Sanjad; E A Al-Sabban; R P Lifton; S W Scherer; F E Karet Journal: Nat Genet Date: 2000-09 Impact factor: 38.330
Authors: Giovanni Gambaro; Emanuele Croppi; Fredric Coe; James Lingeman; Orson Moe; Elen Worcester; Noor Buchholz; David Bushinsky; Gary C Curhan; Pietro Manuel Ferraro; Daniel Fuster; David S Goldfarb; Ita Pfeferman Heilberg; Bernard Hess; John Lieske; Martino Marangella; Dawn Milliner; Glen M Preminger; Jose' Manuel Reis Santos; Khashayar Sakhaee; Kemal Sarica; Roswitha Siener; Pasquale Strazzullo; James C Williams Journal: J Nephrol Date: 2016-07-25 Impact factor: 3.902
Authors: Sílvia Bouissou Morais Soares; Luiz Alberto Wanderley de Menezes Silva; Flávia Cristina de Carvalho Mrad; Ana Cristina Simões E Silva Journal: World J Pediatr Date: 2019-05-11 Impact factor: 2.764
Authors: Marta G Valverde; João Faria; Elena Sendino Garví; Manoe J Janssen; Rosalinde Masereeuw; Silvia M Mihăilă Journal: Pediatr Nephrol Date: 2022-03-14 Impact factor: 3.651
Authors: Marcelo Augusto Duarte Silveira; Antônio Carlos Seguro; Samirah Abreu Gomes; Maria Helena Vaisbich; Lúcia Andrade Journal: Am J Case Rep Date: 2022-01-30